Pharma Foods International Co., Ltd.
株式会社ファーマフーズ
Valuation
Fundamental ratios for the latest reported period.
Ticker: 2929
FY2025 (Jul 2026) · J-GAAP · consolidated Source: filing S100Z9MI
FY = fiscal year, named by the calendar year it starts in; the month in brackets is when it ends (FY2025 ends Mar 2026 for a March year-end). FY2025 (Jul 2026) runs Aug 1, 2025 – Jul 31, 2026.
| Gross margin | 80.2% |
|---|---|
| Operating margin | 4.2% |
| Net margin | 3.1% |
| Return on equity | 16.1%Includes one-off items (e.g. gains on negative goodwill) |
| Return on assets | 5.9% |
| Revenue growth (YoY) | -3.1% |
| EPS (basic) | ¥68.61 |
| EPS growth (YoY) | 434.8% |
| Current ratio | 1.26x |
| Equity ratio | 37.5% |
| Book value / share | ¥453.35 |
| Free cash flow | −¥5.2B |